Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Retina > Study finds DRIL is unfavorable prognostic indicator in diabetic retinopathy
  • Retina

Study finds DRIL is unfavorable prognostic indicator in diabetic retinopathy

Ophthalmology 360

A recent cross-sectional study demonstrated that disorganization of retinal inner layers (DRIL) was strongly associated with diabetic retinopathy (DR) severity and worse visual acuity (VA), supporting its utility as an unfavorable prognostic indicator.

DRIL is a potential spectral-domain optical coherence tomography (SD-OCT) imaging biomarker with clinical utility in DR. The study, which was conducted at a large academic center, included 1,175 participants (n = 2,083 eyes) with type 2 diabetes with and without retinopathy on initial examination between September 2009 and January 2019. DR risk and progression factors were obtained from the medical record. Trained graders masked to patients’ clinical histories evaluated SD-OCT scans for DRIL.

Of 2,083 eyes, 28.1% (n = 585) indicated DRIL presence with high interrater reliability and DRIL was associated with worse VA and DR severity. Insulin users had more severe DR. In addition, DR-related factors, race (Black, White) and sex (male) were significantly associated with DRIL.

Reference:
Singuri S, Luo S, Hatipoglu D, et al. Clinical utility of spectral-domain optical coherence tomography marker disorganization of retinal inner layers in diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2023;54(12):692-700. doi:10.3928/23258160

Share

Related Content

  • Retina

Greater gains seen after aflibercept 8 mg switch in poorly controlled nAMD

  • Retina

Aflibercept 8 mg shows comparable IOP safety to 2 mg through 96 weeks

  • Retina

Biosimilar aflibercept-ayyh demonstrates favorable real-world safety and efficacy

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

  • Retina

Intravitreal therapy in nAMD linked to lower depression and anxiety risk

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon